Andrew Davis

6PUBLICATIONS
61CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2025
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity.

Andrew A Davis, Ellen Jaeger, Ian S Hagemann

|Mar 21, 2025
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.

Foluso O Ademuyiwa, Cynthia X Ma, Katherine Weilbaecher

|Jun 03, 2024
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.

Qiang Zhang, Zheng Cai, Lorenzo Gerratana

|Jun 02, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.

Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton

|Jan 24, 2023
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.

Andrew A Davis, Jingqin Luo, Tiantian Zheng

|Dec 16, 2020
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer.

Saya Jacob, Andrew A Davis, Lorenzo Gerratana

Pageof 1